NEUROCENTRIA, INC.
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2005-01-01
- Employees
- 1
- Market Cap
- -
- Website
- http://www.neurocentria.com
A Phase 2 Randomized Double-Blind, Parallel, Adaptive-Design, Clinical Trial to Evaluate the Safety and Efficacy of NRCT-101SR with NRCT-202XR Compared to NRCT-202XR Alone in Subjects with Attention-Deficit/Hyperactivity Disorder
- Conditions
- ADHD
- Interventions
- Drug: NRCT-101SR, NRCT-202XR
- First Posted Date
- 2024-11-04
- Last Posted Date
- 2025-03-12
- Lead Sponsor
- Neurocentria, Inc.
- Target Recruit Count
- 60
- Registration Number
- NCT06673368
- Locations
- 🇺🇸
Accel Research Site-Maitland Clinical Research Unit, Maitland, Florida, United States
🇺🇸iResearch Atlanta, Decatur, Georgia, United States
🇺🇸CenExel iRS - iResearch Savannah, Savannah, Georgia, United States
Study to Evaluate NRCT-101SR in Pediatric Subjects with ADHD
- Conditions
- Attention-Deficit/Hyperactivity Disorder (ADHD)
- Interventions
- First Posted Date
- 2024-01-22
- Last Posted Date
- 2025-03-12
- Lead Sponsor
- Neurocentria, Inc.
- Target Recruit Count
- 160
- Registration Number
- NCT06215144
- Locations
- 🇺🇸
Advanced Research Center, Inc, Anaheim, California, United States
🇺🇸Accel Research Sites - Lakeland Clinical Research Unit, Lakeland, Florida, United States
🇺🇸Accel Research Sites Network - Maitland, Maitland, Florida, United States
Study to Evaluate NRCT-101SR in Adult Attention Deficit Hyperactivity Disorder (ADHD)
- First Posted Date
- 2023-01-13
- Last Posted Date
- 2025-06-03
- Lead Sponsor
- Neurocentria, Inc.
- Target Recruit Count
- 223
- Registration Number
- NCT05683249
- Locations
- 🇺🇸
Collaborative Neuroscience Network, Garden Grove, California, United States
🇺🇸Accel Research Sites, Maitland, Florida, United States
🇺🇸Miami Dade Medical Research Institute, Miami, Florida, United States
Comparison of MMFS Dosages in Older Adults
- Conditions
- AnxietyDepressionCognitive ImpairmentSleep Quality
- Interventions
- Dietary Supplement: High Dose MMFS-205-SRDietary Supplement: PlaceboDietary Supplement: Low Dose MMFS-205-SR
- First Posted Date
- 2018-07-26
- Last Posted Date
- 2020-09-09
- Lead Sponsor
- Neurocentria, Inc.
- Target Recruit Count
- 9
- Registration Number
- NCT03601169
- Locations
- 🇺🇸
Bio-Kinetic Clinical Applications, LLC, Springfield, Missouri, United States
Efficacy and Safety of MMFS in Early AD
- Conditions
- Alzheimer Disease
- Interventions
- Dietary Supplement: PlaceboDietary Supplement: MMFS-205-SR
- First Posted Date
- 2018-05-22
- Last Posted Date
- 2020-09-09
- Lead Sponsor
- Neurocentria, Inc.
- Target Recruit Count
- 10
- Registration Number
- NCT03531684
- Locations
- 🇺🇸
The Ohio State University Wexner Medical Center, Columbus, Ohio, United States